Dubois Nathan, Crompot Emerence, Meuleman Nathalie, Bron Dominique, Lagneaux Laurence, Stamatopoulos Basile
Laboratory of Clinical Cell Therapy, ULB-Research Cancer Center (U-CRC), Jules Bordet Institute, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Department of Hematology, Jules Bordet Institute, Brussels, Belgium.
Front Oncol. 2020 Aug 19;10:1422. doi: 10.3389/fonc.2020.01422. eCollection 2020.
Chronic lymphocytic leukemia (CLL) is caused by the accumulation of malignant B cells due to a defect in apoptosis and the presence of small population of proliferating cells principally in the lymph nodes. The abnormal survival of CLL B cells is explained by a plethora of supportive stimuli produced by the surrounding cells of the microenvironment, including follicular dendritic cells (FDCs), and mesenchymal stromal cells (MSCs). This crosstalk between malignant cells and normal cells can take place directly by cell-to-cell contact (assisted by adhesion molecules such as VLA-4 or CD100), indirectly by soluble factors (chemokines such as CXCL12, CXCL13, or CCL2) interacting with their receptors or by the exchange of material (protein, microRNAs or long non-coding RNAs) via extracellular vesicles. These different communication methods lead to different activation pathways (including BCR and NFκB pathways), gene expression modifications (chemokines, antiapoptotic protein increase, prognostic biomarkers), chemotaxis, homing in lymphoid tissues and survival of leukemic cells. In addition, these interactions are bidirectional, and CLL cells can manipulate the normal surrounding stromal cells in different ways to establish a supportive microenvironment. Here, we review this complex crosstalk between CLL cells and stromal cells, focusing on the different types of interactions, activated pathways, treatment strategies to disrupt this bidirectional communication, and the prognostic impact of these induced modifications.
慢性淋巴细胞白血病(CLL)是由于凋亡缺陷导致恶性B细胞积累,并主要在淋巴结中存在少量增殖细胞所致。CLL B细胞的异常存活可由微环境中的周围细胞产生的大量支持性刺激来解释,这些细胞包括滤泡树突状细胞(FDC)和间充质基质细胞(MSC)。恶性细胞与正常细胞之间的这种串扰可通过细胞间直接接触(由诸如VLA - 4或CD100等黏附分子辅助)、通过可溶性因子(如CXCL12、CXCL13或CCL2等趋化因子)与其受体相互作用间接发生,或通过细胞外囊泡进行物质(蛋白质、微小RNA或长链非编码RNA)交换来实现。这些不同的通讯方式导致不同的激活途径(包括BCR和NFκB途径)、基因表达修饰(趋化因子、抗凋亡蛋白增加、预后生物标志物)、趋化作用、在淋巴组织中的归巢以及白血病细胞的存活。此外,这些相互作用是双向的,CLL细胞可以通过不同方式操纵周围正常的基质细胞以建立支持性微环境。在此,我们综述CLL细胞与基质细胞之间这种复杂的串扰,重点关注不同类型的相互作用、激活途径、破坏这种双向通讯的治疗策略以及这些诱导修饰的预后影响。